A 25-minute daily exercise programme beat minimal care by nothing
In short
Thirty inpatients aged 8–17 with blood and solid cancers were randomised: one group received 25 minutes of supervised aerobic, resistance and breathing exercise daily, the other received breathing exercises and ambulation guidance only. Comparing admission with discharge, there was no group difference in total fatigue, quality of life, grip strength or six-minute walk distance, and no intervention-related adverse event forced permanent discontinuation. This is not a result saying exercise does nothing — it says the comparator was already moving, the sample was thirty, and actual delivered dose varied.
The result first: between the two randomised groups there was no difference. Total fatigue, its subdomains, overall quality of life, its subdomains, grip strength, six-minute walk distance — not one significant group × time interaction. Some measures shifted over time, but they did not shift differently between groups.
A result like this usually gets headlined as "exercise didn't help". Look at what the control group actually did, and the story changes.
The control group was not lying in bed
The intervention group performed 25 minutes a day of supervised aerobic, resistance and breathing exercise with ambulation guidance. The control group received breathing exercises and ambulation guidance. So the control was not a do-nothing arm but a minimally active one — which is exactly what the paper calls it: a minimal active physiotherapy comparator.
That reframes the question the trial actually asked. Not "is exercise better than nothing?" but "is a structured 25-minute programme better than walking and breathing work?" In this sample, the answer was no.
What was measured
The participants were thirty inpatients aged 8–17 with oncohematological disease — leukaemias, lymphomas and CNS tumours among the most common. Assessment happened twice, at admission and at discharge, across four instruments: the six-minute walk test for endurance, handgrip dynamometry for strength, the PedsQL Multidimensional Fatigue Scale for fatigue, and the PedsQL Cancer Module for quality of life.
There is more than one reason nothing separated
- The comparator was already active. Walking and breathing work alone may prevent much of the deterioration bed rest causes.
- The sample is thirty. Split in two that is roughly fifteen per arm — too few to detect even a moderate difference.
- The patients were clinically heterogeneous. Leukaemia, lymphoma and CNS tumours differ in treatment intensity and course, and an 8-year-old and a 17-year-old differ in baseline capacity.
- Delivered dose varied. The paper states intervention exposure was variable and fidelity data limited — there is no guarantee the planned 25 minutes was completed daily.
- The observation window was the hospital stay. Length of stay differs per patient and may be too short for strength to change meaningfully.
Something was established
No intervention-related adverse event required permanent discontinuation. Daily aerobic and resistance work in children and adolescents hospitalised on cancer treatment was deliverable under close clinical supervision. In this population, that is a reportable finding on its own. The wider picture of what exercise buys through cancer treatment is in exercise cuts colon cancer recurrence and exercise in cancer recovery, and the fatigue relationship is covered in exercise frequency and cancer fatigue.
What to do in a week when your condition collapses
Patient data does not port straight to a healthy lifter. But the contrast this trial produced is worth sitting with: the gap between a carefully designed programme and minimal movement may be smaller than expected when the body is already compromised. In a week wrecked by flu, injury or overwork, engineering a perfect substitute programme may buy less than simply keeping walking and light movement going.
What actually disappears when you stop entirely is in what five days off costs an athlete, and how to place planned rest is in how many rest days. Through a stretch like this, keep logging bodyweight. On return, seeing how far your muscle index actually fell requires both the load and the weight.
This trial ran in thirty children and adolescents hospitalised on cancer treatment, under clinical supervision. The authors themselves flag the small sample, clinical heterogeneity and limited intervention-fidelity data. Exercise during active treatment must be agreed with the treating clinical team.
Frequently asked questions
Does this study mean exercise does not help?
No. The control group received breathing exercises and ambulation guidance, so it was already moving. The comparison was not exercise versus nothing but a structured 25-minute programme versus minimal activity, and no additional benefit over the latter was detected.
What did each group do?
The intervention group performed 25 minutes daily of supervised aerobic, resistance and breathing exercise with ambulation guidance. The control group received breathing exercises and ambulation guidance only. Both were assessed on the same measures at admission and discharge.
What was measured?
Endurance by the six-minute walk test, strength by handgrip dynamometry, fatigue by the PedsQL Multidimensional Fatigue Scale, and quality of life by the PedsQL Cancer Module. None showed a significant group × time interaction.
Why did no difference emerge?
The authors cite the small sample of thirty, clinical heterogeneity across patients, variable intervention exposure and limited fidelity data. Added to that is the design feature that the comparator group was already active.
Was exercising during hospitalisation safe?
In this trial no intervention-related adverse event required permanent discontinuation. That means a daily 25-minute exercise programme could be delivered under close clinical supervision to children and adolescents hospitalised on cancer treatment.
Source: PubMed